Goserelin API is a pharmaceutical-grade synthetic gonadotropin-releasing hormone (GnRH) agonist widely used in hormonal therapy for prostate cancer, breast cancer, endometriosis, uterine fibroids, and assisted reproductive technologies. It works by initially stimulating and subsequently suppressing the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to reduced testosterone or estrogen production.
Goserelin is commonly formulated as long-acting depot injections, providing sustained hormone suppression for effective disease management. It plays a vital role in oncology and gynecology by helping control hormone-dependent diseases and improving patient outcomes.
Swapnroop Drugs and Pharmaceuticals manufactures premium-quality Goserelin API under stringent WHO-GMP manufacturing standards. Every batch undergoes comprehensive testing for purity, peptide content, biological activity, stability, and regulatory compliance. Complete documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), and technical specifications, is available.
Goserelin API is supplied in validated sterile pharmaceutical packaging suitable for commercial manufacturing and clinical applications.
The CAS Number of Goserelin API is 65807-02-5.
Goserelin API is used in the treatment of prostate cancer, breast cancer, endometriosis, uterine fibroids, and in assisted reproductive technologies.
Goserelin acts as a GnRH agonist, suppressing the production of testosterone and estrogen after an initial stimulation phase, helping manage hormone-dependent diseases.
Yes. We provide Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), technical specifications, stability data, and complete regulatory documentation.
Yes. We offer commercial bulk quantities with reliable worldwide export support and customized packaging.
Get Bulk Quote via WhatsApp